Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
65.66
-1.05 (-1.57%)
Aug 25, 2025, 4:00 PM - Market closed
PBH Stock Forecast
Stock Price Forecast
The 5 analysts that cover PBH stock have a consensus rating of "Buy" and an average price target of $94, which forecasts a 43.16% increase in the stock price over the next year. The lowest target is $76 and the highest is $104.
Price Target: $94 (+43.16%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PBH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $105 → $100 | Strong Buy | Maintains | $105 → $100 | +52.30% | Aug 8, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $96 → $97 | Hold | Maintains | $96 → $97 | +47.73% | Mar 21, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $87 → $93 | Buy | Maintains | $87 → $93 | +41.64% | Feb 13, 2025 |
| DA Davidson | DA Davidson | Strong Buy Maintains $95 → $104 | Strong Buy | Maintains | $95 → $104 | +58.39% | Feb 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $93 → $100 | Strong Buy | Maintains | $93 → $100 | +52.30% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
1.12B
from 1.14B
Decreased by -1.74%
Revenue Next Year
1.14B
from 1.12B
Increased by 2.24%
EPS This Year
4.57
from 4.29
Increased by 6.57%
EPS Next Year
4.83
from 4.57
Increased by 5.60%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.2B | ||
| Avg | 1.1B | 1.1B | 1.2B | ||
| Low | 1.1B | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.7% | 6.8% | 6.4% | ||
| Avg | -1.7% | 2.2% | 1.5% | ||
| Low | -5.3% | -1.7% | -2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.78 | 5.09 | 5.12 | ||
| Avg | 4.57 | 4.83 | 4.91 | ||
| Low | 4.41 | 4.55 | 4.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.4% | 11.4% | 6.1% | ||
| Avg | 6.6% | 5.6% | 1.7% | ||
| Low | 2.8% | -0.5% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.